Charles Williams
Director of Finance/CFO bij SURROZEN, INC.
Vermogen: 23 157 $ op 31-03-2024
Profiel
Charles Williams is currently the Chief Operating & Financial Officer at Surrozen, Inc. He previously worked as the Director-Corporate & Business Development at MAP Pharmaceuticals LLC from 2008 to 2013, and as the Head-Corporate Development at Jazz Pharmaceuticals Plc from 2013 to 2020.
Mr. Williams completed his undergraduate degree at Cornell University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SURROZEN INC
0.07% | 04-04-2024 | 1 474 ( 0.07% ) | 23 157 $ | 31-03-2024 |
Actieve functies van Charles Williams
| Bedrijven | Functie | Begin |
|---|---|---|
| SURROZEN, INC. | Director of Finance/CFO | 01-11-2020 |
Eerdere bekende functies van Charles Williams
| Bedrijven | Functie | Einde |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 01-11-2020 |
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Corporate Officer/Principal | 01-01-2013 |
Opleiding van Charles Williams
| Cornell University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| SURROZEN, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Health Technology |
